Specify Company / Ticker to Get the Summary
Dividend History ENZ
Dividend Analytics ENZ
Max Ratio
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
178.08 %Enzo Biochem Inc
ENZEnzo Biochem, Inc., a life sciences company, engages in the labeling and detection technologies from DNA to whole cell analysis in the United States and internationally. The company offers labels, dyes, antibodies, genomic probes, immunoassays, biochemicals, and proteins are used to label, detect, and visualize a biological target of interest in drug discovery exploration and drug development process development. Its proprietary products and technologies play roles in translational research and drug development areas, including cell biology, genomics, assays, immunohistochemistry, and small molecule chemistry. The company licenses its technology. It serves academic researchers, clinical researchers, biotechnology and pharmaceutical companies, and diagnostic manufacturers. Enzo Biochem, Inc. was incorporated in 1976 and is headquartered in Farmingdale, New York. Address: 21 Executive Blvd, Farmingdale, NY, United States, 11735
Analytics
WallStreet Target Price
5.50 USDP/E Ratio
–Dividend Yield
125.00 %Financials ENZ
Results | 2019 | Dynamics |